Barclays

Barclays’s Relay Therapeutics RLAY Stock Holding History

Barclays’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$450K	Sell	45,267 -368,876	-89%	-$3.3M	﹤0.01%	3250
2025 Q4	$3.5M	Sell	414,143 -47,736	-10%	-$341K	﹤0.01%	2501
2025 Q3	$2.41M	Sell	461,879 -94,643	-17%	-$361K	﹤0.01%	2754
2025 Q2	$1.93M	Buy	556,522 +87,351	+19%	+$260K	﹤0.01%	2879
2025 Q1	$1.23M	Buy	469,171 +155,969	+50%	+$611K	﹤0.01%	2977
2024 Q4	$1.29M	Buy	313,202 +61,383	+24%	+$334K	﹤0.01%	3204
2024 Q3	$1.78M	Buy	251,819 +136,541	+118%	+$1.02M	﹤0.01%	2945
2024 Q2	$752K	Sell	115,278 -24,718	-18%	-$169K	﹤0.01%	2774
2024 Q1	$1.16M	Sell	139,996 -154,789	-53%	-$1.51M	﹤0.01%	2995
2023 Q4	$3.25M	Buy	294,785 +79,316	+37%	+$669K	﹤0.01%	2493
2023 Q3	$1.81M	Sell	215,469 -93,710	-30%	-$1.01M	﹤0.01%	1958
2023 Q2	$3.88M	Buy	309,179 +114,709	+59%	+$1.43M	﹤0.01%	1488
2023 Q1	$3.2M	Sell	194,470 -77,369	-28%	-$1.39M	﹤0.01%	1849
2022 Q4	$4.06M	Buy	271,839 +121,628	+81%	+$2.33M	﹤0.01%	1769
2022 Q3	$3.36M	Buy	150,211 +80,404	+115%	+$1.76M	﹤0.01%	1403
2022 Q2	$1.17M	Sell	69,807 -6,261	-8%	-$134K	﹤0.01%	2225
2022 Q1	$2.28M	Buy	+76,068	New	+$1.85M	﹤0.01%	1771

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return